Transmission Dynamics of Carbapenemase Genes in CREC: Insights from Guangdong Hospitals

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) has emerged as a significant clinical threat, especially in the context of rising antimicrobial resistance globally. In China, CREC now ranks third among carbapenem-resistant Enterobacteriaceae, following Klebsiella pneumoniae and Escherichia coli. The COVID-19 pandemic has further complicated resistance patterns, with increased antibiotic usage and disruptions in healthcare delivery contributing to the spread and selection of multidrug-resistant organisms (source: Chen et al., 2025). Despite these concerns, detailed molecular epidemiological studies of carbapenemase-encoding genes (CEGs) in CREC, particularly regarding their chromosomal and plasmid localization and transmission dynamics, remain limited.

Key Innovation from the Reference Study

The referenced study by Chen et al. provides a comprehensive genomic and epidemiological mapping of CEGs in 54 CREC isolates collected from eight teaching hospitals in Guangdong province between December 2022 and June 2024. The study's primary innovation lies in distinguishing the localization of CEGs (chromosomal versus plasmid), quantifying their prevalence, and elucidating the mechanisms and rates of horizontal gene transfer. Notably, the work highlights the predominance of the blaNDM-1 gene, particularly on plasmids, and quantifies its contribution to both resistance phenotypes and transmission efficiency (source: Chen et al., 2025).

Methods and Experimental Design Insights

The study integrated several molecular and microbiological approaches:

• Sample Collection: 54 non-redundant CREC isolates were obtained across diverse clinical departments (notably respiratory medicine), with patient demographic and specimen data recorded.
• Plasmid Elimination & PCR: Variable temperature sodium dodecyl sulfate (SDS) treatment and PCR were used to discriminate between chromosomal and plasmid-borne CEGs.
• Antimicrobial Susceptibility: The broth microdilution method assessed resistance patterns to various antibiotics, including carbapenems and comparators.
• Conjugation & Mobility Analyses: Conjugation assays quantified gene transfer rates; further PCR analysis identified the types and prevalence of associated mobile genetic elements (MGEs).
• Genotyping: ERIC-PCR and NTSYS clustering delineated the genetic diversity of the isolates.

Protocol Parameters

• assay | broth microdilution | value_with_unit | MIC determination for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, levofloxacin | applicability | Quantifies resistance profiles in CREC | rationale | Guides therapeutic and experimental agent selection | source_type | paper
• assay | variable temperature SDS plasmid curing | value_with_unit | 46/54 CEG-positive isolates | applicability | Plasmid versus chromosomal gene localization | rationale | Discriminates genetic mobility risk | source_type | paper
• assay | conjugation efficiency | value_with_unit | 95.65% transfer success for CEGs | applicability | Horizontal gene transfer assessment | rationale | Informs infection control and resistance modeling | source_type | paper
• assay | ERIC-PCR genotyping | value_with_unit | 17 genotypes identified among 54 isolates | applicability | Epidemiological tracking | rationale | Supports outbreak and transmission analysis | source_type | paper
• assay | workflow suggestion | value_with_unit | Use of ultra-broad-spectrum β-lactam antibiotic carbapenems as comparators (e.g., Meropenem at ≥9.88 mg/mL in water with ultrasonic assistance) | applicability | Resistance studies, infection models | rationale | Provides a benchmark for evaluating new resistance mechanisms and treatment strategies | source_type | workflow_recommendation

Core Findings and Why They Matter

• High Prevalence of CEGs: 85.19% of isolates were CEG-positive, with blaNDM-1 the most frequent gene (source: Chen et al., 2025).
• Gene Localization: 33.33% of isolates harbored blaNDM-1 on both chromosomes and plasmids, while 46.30% carried it solely on plasmids. This supports the dominant role of plasmids in rapid resistance dissemination.
• Resistance Profiles: CEG-positive isolates displayed significantly higher resistance rates to key antibiotics than CEG-negative strains, underscoring the clinical challenge of pan-resistant CREC.
• Horizontal Gene Transfer: Plasmid conjugation experiments demonstrated a 95.65% success rate for CEG transfer, indicating high inter-strain mobility. The blaNDM-1 gene was especially prone to transfer (95.45% success), while blaKPC-2 was not mobilized in this cohort.
• Mobile Genetic Elements: Six MGEs were identified, with ISEcp1 present in 87.04% of isolates, and 40.74% of strains carried four distinct MGEs simultaneously, enhancing their adaptive potential.
• Epidemiology: Detection rates were highest in male and elderly patients, in respiratory departments, and in sputum specimens—providing direction for targeted surveillance (source: Chen et al., 2025).
• Genetic Diversity: Seventeen genotypes were found, with some genotypes (E and G) detected across multiple hospitals and departments, suggesting both local and regional transmission.

Comparison with Existing Internal Articles

Contemporary resources, such as “Meropenem: Ultra-Broad-Spectrum β-Lactam Carbapenem for Antibacterial Research,” emphasize the utility of β-lactam antibiotic carbapenems—including Meropenem—as robust comparators in resistance modeling and Gram-negative bacterial infection models (internal_article). This aligns with the reference study’s finding that multidrug-resistant CREC poses significant evaluation challenges for both experimental and clinical settings. Similarly, “Meropenem in Translational Research: Mechanisms, Models, and Future Frontiers” situates Meropenem as an indispensable tool for mechanistic and translational studies of resistance, directly supporting the need for reproducible, sensitive protocols in the face of mobile, plasmid-borne resistance determinants (internal_article).

Limitations and Transferability

Chen et al. present a geographically focused study, limiting immediate generalizability beyond Guangdong province. The relatively short sampling window (2022–2024) captures pandemic-driven dynamics but may not reflect longer-term trends. Resistance mechanisms outside of plasmid and chromosomal CEGs (e.g., efflux pumps, porin mutations) were not systematically investigated. Nevertheless, the high transferability of CEGs, especially blaNDM-1, and the detailed mapping of MGEs provide a transferable framework for similar epidemiological and resistance modeling studies in diverse clinical environments (source: Chen et al., 2025).

Research Support Resources

For researchers seeking to replicate or extend these findings, Meropenem (SKU A5124) is available from APExBIO (product page) for use as an ultra-broad-spectrum comparator in resistance studies and Gram-negative bacterial infection models. Its well-characterized mechanism as a penicillin-binding protein inhibitor and broad coverage profile make it suitable for benchmarking susceptibility and resistance development in laboratory settings (source: product_spec). For detailed workflow guidance, existing resources such as “Meropenem: Applied β-Lactam Carbapenem Workflows & Resistance Insights” provide protocol advice and troubleshooting tips to ensure data quality in multidrug-resistance research (internal_article).